MBX Biosciences, Inc.
SEC CIK 1776111 · MBX · last insider filing 2026-06-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mathers Edward T | Director | filed 2024 - 2026 |
| Heron Patrick J | Director | filed 2024 - 2026 |
| Pescovitz Ora H. | Director | filed 2024 - 2026 |
| Hoerter Steven L. | Director | filed 2025 - 2026 |
| Stelzer Laurie | Director | filed 2026 - 2026 |
| Aynechi Tiba | Director | filed 2024 - 2026 |
| Ryder Steven | Director | filed 2024 - 2026 |
| Hawryluk P. Kent | Director · President & CEO | filed 2024 - 2026 |
| Cornelius James M | Director | filed 2024 - 2025 |
| Orbimed Advisors LLC | Director | filed 2024 - 2025 |
| Gordon Carl L | Director | filed 2024 - 2025 |
| Orbimed Capital GP VII LLC | Director | filed 2024 - 2025 |
| Orbimed Genesis GP LLC | Director | filed 2024 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Azoulay Salomon | Chief Medical Officer | filed 2024 - 2026 |
| Smither John W | Chief Financial Officer | filed 2026 - 2026 |
| Bartram Richard | Chief Financial Officer | filed 2024 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.